Aurobindo Pharma gets USFDA final nod for generic anti-epileptic drug

Aurobindo Pharma has received final nod from the US health regulator to make and market generic anti-epileptic Phenytoin Sodium capsules in America.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news